Kawasaki, Japan

Hiroyuki Izawa

This inventor holds 12 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1994-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Izawa. Retrieved from https://idiyas.com/inventor/hiroyuki-izawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

Average Co-Inventor Count = 8.7

ph-index = 7

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1994-2013

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Hiroyuki Izawa

Introduction

Hiroyuki Izawa is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on phenylalanine derivatives. With a total of 12 patents to his name, Izawa's innovations have the potential to impact therapeutic treatments for various diseases.

Latest Patents

Izawa's latest patents focus on specified phenylalanine derivatives and analogues that exhibit antagonistic activity to α4 integrin. These compounds are being explored as therapeutic agents for diseases associated with α4 integrin, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Hiroyuki Izawa has been associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Izawa has collaborated with notable colleagues such as Toshihiko Yoshimura and Masahiro Murata. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Hiroyuki Izawa's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic agents, making a lasting impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…